-
公开(公告)号：US07604112B1
公开(公告)日：2009-10-20
申请号：US12215848
申请日：2008-06-30
Applicant: Rick Lee
Inventor： Rick Lee
IPC: B65G21/16
Abstract: The present invention is related to interlockers or beadings that are attached to the outer edges of conveyor belts. Interlockers and/or beadings are reinforced with aramid fibers to improve their durability.
Abstract translation: 本发明涉及连接到输送带的外边缘的互锁器或滚珠。 用芳族聚酰胺纤维增强了联锁和/或珠饰以提高其耐久性。
-
12.发明申请公开(公告)号：US20080269190A1
公开(公告)日：2008-10-30
申请号：US12148887
申请日：2008-04-23
Applicant: Craig Husfeld , YuHua Ji , Rick Lee , Li Li , YongQi Mu , Cameron Smith , Johnny Uy
Inventor： Craig Husfeld , YuHua Ji , Rick Lee , Li Li , YongQi Mu , Cameron Smith , Johnny Uy
IPC: A61K31/397 , C07D211/58 , A61K31/4468 , C07D405/06 , A61P11/00 , A61K31/453 , C07D205/04
CPC classification number: C07D409/14 , C07D205/04 , C07D211/26 , C07D211/58 , C07D401/12 , C07D405/06 , C07D405/12 , C07D409/06 , C07D409/12
Abstract: The invention provides compounds of the formula: in salt or zwitterionic form or a pharmaceutically acceptable salt thereof, wherein R1-6, a, Z and Q are as defined in the specification. These compounds are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes for preparing such compounds and methods of using such compounds to, for example, treat pulmonary disorders such as chronic obstructive pulmonary disease and asthma.
Abstract translation: 本发明提供下式的化合物：盐或两性离子形式或其药学上可接受的盐，其中R 1-6，a，Z和Q如说明书中所定义。 这些化合物是毒蕈碱受体拮抗剂。 本发明还提供含有这些化合物的药物组合物，制备这些化合物的方法和使用这些化合物例如治疗慢性阻塞性肺疾病和哮喘等肺疾病的方法。
-
-
14.发明授权Induction drive for induction driven conveyor including a virtual continuous magnetic body and method of driving induction driven conveyor including a virtual continuous magnetic body 有权用于感应驱动输送机的感应驱动器包括虚拟连续磁体和驱动感应驱动输送机的方法，包括虚拟连续磁体公开(公告)号：US06528908B1
公开(公告)日：2003-03-04
申请号：US09973271
申请日：2001-10-09
Applicant: Rick Lee
Inventor： Rick Lee
IPC: B65G3502
Abstract: The invention is related to induction drives for either straight or curved conveyors as well as methods of driving endless conveyor belts. Pivotable magnets are free floating in holders or interconnected to create a virtual continuous magnetic body. When the virtual continuous magnetic body encounters the stator's electromagnetic field the resultant magnetic flux pushes the continuous magnetic body through the groove of the conveyor bed. The pivotable magnets are dimensioned so they will not interlock with each other, as their pathways are reversed.
Abstract translation: 本发明涉及用于直线或弯曲输送机的感应驱动器以及驱动无端传送带的方法。 可转动磁铁可自由浮动在支架上或相互连接以产生虚拟的连续磁体。 当虚拟连续磁体遇到定子的电磁场时，所得的磁通量将连续的磁体推动通过输送机床的凹槽。 可枢转磁体的尺寸设计使得它们不会互相互锁，因为它们的路径相反。
-
15.发明授权公开(公告)号：US09216971B2
公开(公告)日：2015-12-22
申请号：US14335097
申请日：2014-07-18
Applicant: Craig Husfeld , YuHua Ji , Rick Lee , Li Li , YongQi Mu , Cameron Smith , Johnny Uy
Inventor： Craig Husfeld , YuHua Ji , Rick Lee , Li Li , YongQi Mu , Cameron Smith , Johnny Uy
IPC: C07D405/12 , C07D409/12 , C07D401/12 , C07D409/14 , C07D205/04 , C07D211/26 , C07D211/58 , C07D405/06 , C07D409/06
CPC classification number: C07D409/14 , C07D205/04 , C07D211/26 , C07D211/58 , C07D401/12 , C07D405/06 , C07D405/12 , C07D409/06 , C07D409/12
Abstract: The invention provides compounds of the formula: in salt or zwitterionic form or a pharmaceutically acceptable salt thereof, wherein R1-6, a, Z and Q are as defined in the specification. These compounds are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes for preparing such compounds and methods of using such compounds to, for example, treat pulmonary disorders such as chronic obstructive pulmonary disease and asthma.
Abstract translation: 本发明提供下式的化合物：盐或两性离子形式或其药学上可接受的盐，其中R1-6，a，Z和Q如说明书中所定义。 这些化合物是毒蕈碱受体拮抗剂。 本发明还提供含有这些化合物的药物组合物，制备这些化合物的方法和使用这些化合物例如治疗慢性阻塞性肺疾病和哮喘等肺疾病的方法。
-
Patent Agency Ranking
16.发明申请QUATERNARY AMMONIUM COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS 审中-公开季铵化合物作为MUSCARINIC受体拮抗剂有用公开(公告)号：US20140329857A1
公开(公告)日：2014-11-06
申请号：US14335097
申请日：2014-07-18
Applicant: Craig Husfeld , YuHua Ji , Rick Lee , Li Li , YongQi Mu , Cameron Smith , Johnny Uy
Inventor： Craig Husfeld , YuHua Ji , Rick Lee , Li Li , YongQi Mu , Cameron Smith , Johnny Uy
IPC: C07D409/14 , C07D405/06 , C07D409/06 , C07D211/58 , C07D401/12
CPC classification number: C07D409/14 , C07D205/04 , C07D211/26 , C07D211/58 , C07D401/12 , C07D405/06 , C07D405/12 , C07D409/06 , C07D409/12
Abstract: The invention provides compounds of the formula: in salt or zwitterionic form or a pharmaceutically acceptable salt thereof, wherein R1-6, a, Z and Q are as defined in the specification. These compounds are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes for preparing such compounds and methods of using such compounds to, for example, treat pulmonary disorders such as chronic obstructive pulmonary disease and asthma.
Abstract translation: 本发明提供下式的化合物：盐或两性离子形式或其药学上可接受的盐，其中R1-6，a，Z和Q如说明书中所定义。 这些化合物是毒蕈碱受体拮抗剂。 本发明还提供含有这些化合物的药物组合物，制备这些化合物的方法和使用这些化合物例如治疗慢性阻塞性肺疾病和哮喘等肺疾病的方法。
-
17.发明授权公开(公告)号：US08815907B2
公开(公告)日：2014-08-26
申请号：US13921396
申请日：2013-06-19
Applicant: Craig Husfeld , YuHua Ji , Rick Lee , Li Li , YongQi Mu , Cameron Smith , Johnny Uy
Inventor： Craig Husfeld , YuHua Ji , Rick Lee , Li Li , YongQi Mu , Cameron Smith , Johnny Uy
IPC: A61K31/445 , C07D405/06
CPC classification number: C07D409/14 , C07D205/04 , C07D211/26 , C07D211/58 , C07D401/12 , C07D405/06 , C07D405/12 , C07D409/06 , C07D409/12
Abstract: The invention provides compounds of the formula: in salt or zwitterionic form or a pharmaceutically acceptable salt thereof, wherein R1-6, a, Z and Q are as defined in the specification. These compounds are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes for preparing such compounds and methods of using such compounds to, for example, treat pulmonary disorders such as chronic obstructive pulmonary disease and asthma.
Abstract translation: 本发明提供下式的化合物：盐或两性离子形式或其药学上可接受的盐，其中R1-6，a，Z和Q如说明书中所定义。 这些化合物是毒蕈碱受体拮抗剂。 本发明还提供含有这些化合物的药物组合物，制备这些化合物的方法和使用这些化合物例如治疗慢性阻塞性肺疾病和哮喘等肺疾病的方法。
-
18.发明授权Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists 有权可用作毒蕈碱受体拮抗剂的季铵二苯基甲基化合物公开(公告)号：US08592453B2
公开(公告)日：2013-11-26
申请号：US12898858
申请日：2010-10-06
Applicant: YuHua Ji , Craig Husfeld , Christopher Lange , Rick Lee , YongQi Mu
Inventor： YuHua Ji , Craig Husfeld , Christopher Lange , Rick Lee , YongQi Mu
IPC: A61K31/40 , A61K31/44 , C07D207/08 , C07D211/70 , C07D211/26 , C07D207/18
CPC classification number: C07D207/09 , C07D207/08 , C07D207/48
Abstract: The invention provides compounds of formula I: in salt or zwitterionic form or a pharmaceutically acceptable salt thereof, wherein R1-6, a-e and Q are as defined in the specification. These compounds are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes for preparing such compounds and methods of using such compounds to, for example, treat pulmonary disorders such as chronic obstructive pulmonary disease and asthma.
Abstract translation: 本发明提供式I化合物：盐或两性离子形式或其药学上可接受的盐，其中R1-6，a-e和Q如说明书中所定义。 这些化合物是毒蕈碱受体拮抗剂。 本发明还提供含有这些化合物的药物组合物，制备这些化合物的方法和使用这些化合物例如治疗慢性阻塞性肺疾病和哮喘等肺疾病的方法。
-
19.发明申请GUANIDINE-CONTAINING COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS 有权含有胍类化合物的药物可用作MUSCARINIC RECEPTOR ANTAGONISTS公开(公告)号：US20130267706A1
公开(公告)日：2013-10-10
申请号：US13681794
申请日：2012-11-20
Applicant: YuHua Ji , Craig Husfeld , YongQi Mu , Rick Lee , Li Li
Inventor： YuHua Ji , Craig Husfeld , YongQi Mu , Rick Lee , Li Li
IPC: C07D333/24 , C07D307/52
CPC classification number: C07D333/24 , C07D209/14 , C07D213/38 , C07D231/12 , C07D277/28 , C07D295/13 , C07D307/52 , C07D307/81 , C07D317/58 , C07D333/20 , C07D333/58
Abstract: The invention provides compounds of formula I: or a pharmaceutically acceptable salt thereof, wherein R1-3, R5-7, a, X, Y, Y′, Y″, and Z are as defined in the specification. These compounds are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes for preparing such compounds and methods of using such compounds to, for example, treat pulmonary disorders such as chronic obstructive pulmonary disease and asthma.
Abstract translation: 本发明提供式I化合物或其药学上可接受的盐，其中R1-3，R5-7，a，X，Y，Y'，Y“和Z如说明书中所定义。 这些化合物是毒蕈碱受体拮抗剂。 本发明还提供含有这些化合物的药物组合物，制备这些化合物的方法和使用这些化合物例如治疗慢性阻塞性肺疾病和哮喘等肺疾病的方法。
-
公开(公告)号：US08492407B2
公开(公告)日：2013-07-23
申请号：US13473792
申请日：2012-05-17
Applicant: Craig Husfeld , YuHua Ji , Rick Lee , Li Li , YongQi Mu , Cameron Smith , Johnny Uy
Inventor： Craig Husfeld , YuHua Ji , Rick Lee , Li Li , YongQi Mu , Cameron Smith , Johnny Uy
IPC: A61K31/445 , C07D409/06
CPC classification number: C07D409/14 , C07D205/04 , C07D211/26 , C07D211/58 , C07D401/12 , C07D405/06 , C07D405/12 , C07D409/06 , C07D409/12
Abstract: The invention provides compounds of the formula: in salt or zwitterionic form or a pharmaceutically acceptable salt thereof, wherein R1-6, a, Z and Q are as defined in the specification. These compounds are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes for preparing such compounds and methods of using such compounds to, for example, treat pulmonary disorders such as chronic obstructive pulmonary disease and asthma.
-
-
-
-
-
-
-
-
-
Search Results
36
records
(took 0.03 seconds)
